Advances in the research on nicotinic acetylcholine receptors agonists

Yaoxue Xuebao

Volumn 37, Issue 4, 2002, Pages 309-315

  Chen, Jian Hong ^a   Bai, Dong Lu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Agonist; Nicotinic acetylcholine receptors; Structure activity relationship

Indexed keywords

5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE; 5-(2-AZETIDINYLMETHOXY)-2-CHLOROPYRIDINE; ANALGESIC AGENT; AZETIDINE DERIVATIVE; EPIBATIDINE; FUSED HETEROCYCLIC RINGS; NICOTINIC AGENT; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANALGESICS, NON-NARCOTIC; ANIMALS; AZETIDINES; BICYCLO COMPOUNDS, HETEROCYCLIC; HUMANS; MOLECULAR STRUCTURE; NICOTINIC AGONISTS; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0041881935     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Xu R, Bai DL. Chemistry and pharmacology of new potent analgesic epibatidine [J]. Prog Chem, 1999,11(3):313-326.
2. Singh S, Avor KS, Pouw B, et al. Design and synthesis of isoxazole containing bioisosteres of epibatidine as potent nicotinic acetylcholine receptor agonists [J]. Chem Pharm Bull, 1999,47(10):1501-1505.
3. Shen TY, Harman WD, Huang DF, et al. 7-Azabicyclo[2. 2.1]-heptane and-heptene derivatives as cholinergic receptor ligands [P]. World Pat: 06093A1, USA, 1996 - 02 - 29.
4. Rádl S, Hezky P, Hafner W, et al. Synthesis and binding studies of some epibatidine analogues [J]. Bioorg Med Chem Lett, 2000,10(1):55-58.
5. Seerden JPG, Tulp MTM, Scheeren HW, et al. Synthesis and structure-activity data of some new epibatidine analogues [J]. Bioorg Med Chem, 1998,6(3):2103-2110.
6. Barlocco D, Cignarella G, Tondi D, et al. Mono-and disubstituted-3,8-diazabicyclo [3. 2. 1] octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modelling [J]. J Med Chem, 1998,41(1):674 -681.
7. Bencherif M, Schmitt JD, Bhatti BS, et al. The heterocyclic substituted pyridine derivative ( ± )-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors [J]. J Pharmacol Exp Ther, 1998,284(3):886-894.
8. Choi KI, Cha JH, Cho YS, et al. Binding affinities of 3-(3-phenylisoxazol-5-yl) methylidene-1-azabicycles to acetylcholine receptors [J]. Bioorg Med Chem Lett, 1999,9(4):2795 -2800.
9. Spang JE, Patt JT, Bertrand S, et al. Synthesis and electrophysiololgical studies of a novel epibatidine analogue [J]. J Recept Signal Trans Res, 1999,19(1-4):521-531.
10. Tønder JE, Hansen JB, Begtrup M, et al. Improving the nicotinic pharmacophore with a series of (isoxazole) methylene-1-azacyclic compounds: synthesis, structure-acticity relationship, and molecular modeling [J]. J Med Chem, 1999,42(24):4970-4980.
11. Olesen PH, Tønder JE, Hansen JB, et al. Bioisosteric replacenent. Strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors [J]. Bioorg Med Chem, 2000,8(5): 1441-1450.
12. Krow GR, Cheung OH, Hu Z, et al. Nitrogen bridge homoepibatidines. syn-6- and syn-5-(6-chloro-3-pyridyl) isoquinaclidines [J]. Tetrahedron, 1999,55(20):7747-7756.
13. Krow GR, Yuan J, Huang Q, et al. Synthesis of 5- and 6-(6-chloro-3-pyridyl)-2-azabicyclo [2. 2. 0] hexanes. Epibatidine analogs [J]. Tetrahedron, 2000,56(25):9233 -9239.
14. Bai D, Xu R, Chu G, et al. Synthesis of (±)-epibatidine and its analogues [J]. J Org Chem, 1996,61(14):4600-4606.
15. Che D, Wegge T, Stubbs MT, et al. Exo-2-(pyridazin-4-yl)-7-azabicyclo[2. 2. 1] heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (±)-epibatidine [J]. J Med Chem, 2001,44 (1):47-57.
16. Holladay MW, Wasicak JT, Lin NH, et al. Identification and initial structure-activity relationships of (R)-5-(2-azatidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors [J]. J Med Chem, 1998,41 (4):407-412.
17. Bannon AW, Decker MW, Holladay MW, et al. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors [J]. Science, 1998,279(2):77-81.
18. Strauss E. New nonopioid painkiller shows promise in animal tests [J]. Science, 1998,279(2):32-33.
19. Cheng YX, Dukat M, Dowd M, et al. Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors [J]. Eur J Med Chem, 1999,34(1):177-190.
20. Dukat M, Dowd M, Damaj MI, et al. Synthesis, receptor binding and QSAR studies on 6- substituted nicotine derivatives as cholinergic ligands [J]. Eur J Med Chem, 1999,34(1):1-40.
21. Elliott RL, Ryther KB, Holladay MW, et al. Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pridazine and thiazine compounds useful in control chemical synaptic transmission [P]. World Pat: 46609A1, USA, 1998 - 10 - 22.
22. Lee J, Davis CB, Rivero RA, et al. Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor [J]. Bioorg Med Chem Lett, 2000,10 (10):1063-1066.
23. 2 subtype-selective ligand for nicotinic acetylcholine receptors [J]. Mol Pharmacol, 2000,57(4):642-649.
24. Schneider JS, Tinker JP, Velson MV, et al. Nicotinic acetylcholine receptor agonist SIB- 1508Y improves cognitive functioning in chronic low-dose MPTP- treated monkeys [J]. J Pharm Exp Ther, 1999,290(2):731-739.
25. Krow GR, Yuan J, Fang Y, et al. Synthesis of 3- and 5-endo-(6-chloro-3-pyridoxy)-methyl-2-azabicyclo[2. 2. 0] hexane and 3-endo-(6-chloro-3-pyridoxy)-methyl-2-azabicyclo [2. 2. 0] hex-5-ene. ABT-594 analogs [J]. Tetrahedron, 2000,56(20):9227-9232.
26. Tomizawa M, Casid JE. Minor structural changes in nicotinoid insecticides confer differential subtype selectivity for mammalian nicotinic acetylcholine receptors [J]. Br J Pharmacol, 1999,127(1):115-122.
27. Gotti C, Balestra B, Moretti M, et al. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic α-bungarotoxin receptors [J]. Br J Pharmacol, 1998,124(6): 11971-1206.
28. Wasicak JT, Garvey DS, Holladay MW, et al. 7A-Heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission [P]. US Pat: 5733912, 1998 - 03 - 31.
29. Balbon G, Marastoni M, Meright S, et al. Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors [J]. Eur J Med Chem, 2000,35(5):979-988.
30. Damaj MI, Glassco W, Aceto MD, et al. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist [J]. J Pharm Exp Ther, 1999,291(1): 3903-98.
31. Ferguson SM, Brodkin JD, Lloyd GK, et al. Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist SIB-1508Y, in the learned helplessness rat model of depression [J]. Psychopharmacology, 2000, 152 (1):295-303.
32. Takahata H, Takahashi S, Azer N, et al. Total synthesis of pyrrolizidines 223H′, 239K′, 265H′ and 267H′ found in Madagascan Frogs (Mantella) and their affinities for nicotinic acetylcholine receptor [J]. Bioorg Med Chem Lett, 2000,10 (8):1293-1295.
33. 125I-α-bungarotoxin receptor subtypes [J]. Mol Pharmacol, 1995, 47(1):164-171.
34. Meyer EM, kuryatov A, Gerzanich V, et al. Analysis of 3-(4-hydroxy,2-methosybenzylidene) anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptor [J]. J Pharm Exp Ther, 1998,287(5):918-925.
35. Flammia D, Dukat M, Damaj MI, et al. Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding [J]. J Med Chem, 1999,42(18):3726-3731.
36. Terry-Jr AV, Williamson R, Gattu M, et al. Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine [J]. Neuropharmacology, 1998, 37 (1): 93-102.
37. Zhang X, Gong ZH, Fasth KJ, et al. Interaction of the nicotinic agonist (R, S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex [J]. Neurochem Int, 1998,32(3):435-441.
38. Olesen PH, Swedberg MDB, Rimvau K. 3-(5-Alkylamino-4-isoxazo(yl)-1, 2, 5, 6-tetrahydropyridines: a novel class of central nicotinic receptor ligands [J]. Bioorg Med Chem, 1998,6(5):1623-1629.
39. Garvey DS, Wasicak JT, Decker MW, et al. Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities [J]. J Med Chem, 1994,37(8):1055-1059.
40. Lin NH, Gunn DE, Ryther KB, et al. Structure-activiity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties [J]. J Med Chem, 1997,40(3):385-390.
41. 125I-α-bungarotoxin receptor subtypes [J]. Mol Pharmacol, 1995, 47(1):164-171.
42. Vernier JM, El-Abdellaoui H, Holsenback H, et al. 4-((2-(1-Methyl-2-pyrrolidinyl) ethyl) thio)-phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors [J]. J Med Chem, 1999,42(10):1684-1686.
43. Mullen G, Napier J, Balestra M, et al. (-)-Spiro (1-azabicyclo [ 2. 2. 2] octane-3, 5′-oxazolidin-2′-one), a conformationally restricted analogue of acetylcholine, is a highly selective gull agonist at the α7 nicotinic acetylcholine receptor [J]. J Med Chem, 2000,43(22):4045-4050.
44. 4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action [J]. Bioorg Med Chem, 1999,7(2):457-465.
45. Nielsen SF, Nielsen EQ, Olsen GM, et al. Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis [J]. J Med Chem, 2000,43(11):.2217-2226.
46. 2 receptor subtype [J]. J Neurochem, 2000,75(1):204-216.
47. 2 nicotinic acetylcholine receptors: structure-acrivity relationships and molecular modelling [J]. Curr Med Chem, 2001,8(6):651 -674.